• News
  • SAN DIEGO
  • BioTech

Seragon appoints N. Anthony Coles to board

San Diego-based Seragon Pharmaceuticals Inc., a clinical-stage biotechnology company focused on the development of drugs for hormone-driven cancers, has appointed N. Anthony Coles, M.D., to the company's board of directors.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!